| Molecular formula | C17H22N2O4 |
|---|
| Molecular weight | 318.4 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 180496 |
|---|
What Noopept Is
Noopept is a synthetic compound with the molecular formula C17H22N2O4 and a molecular weight of about 318.4 g/mol (PubChem CID 180496). It has no FDA-approved label, meaning there is no agency-reviewed information on indications, mechanism, or safety for human use. No brand names, pharmacologic class, or boxed warning data are available because no approved labeling exists.
Clinical Trial Footprint
There are no registered clinical trials for noopept in the dataset reviewed. This means there is currently no sample of trial titles, phases, or statuses to summarize. The absence of registered trials reflects the compound's status as an unapproved research substance rather than a marketed or clinically studied drug.
FAQ
No. Noopept has no FDA-approved label, which means there are no agency-reviewed indications, dosing guidance, or safety information available for it. It is classified as an unapproved research compound.
Noopept has the molecular formula C17H22N2O4 and a molecular weight of approximately 318.4 g/mol. It is cataloged in PubChem under CID 180496, which provides its structural and chemical reference data.
Based on the data reviewed, there are no registered clinical trials for noopept. This means there is no available trial data on phases, participant outcomes, or study status to reference.
No adverse event report data is available for noopept in the dataset reviewed. Without an approved label or trial history, there is no structured safety profile to summarize at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 180496
Updated 2026-09-19